Kowa Pharmaceutical Europe Co. Ltd.
Kowa Pharmaceutical Europe Co. Ltd. is a specialty pharmaceutical company located in the UK and is a division of Kowa Company, LTD., a multinational Japanese company actively engaged in a broad variety of manufacturing and trading activities. Kowa are committed to ground-breaking research, development and marketing, seeking to ensure quality products are made available to people within Europe and beyond, to contribute to a better standard of health and a more comfortable life for all. Find out more.
2nd – 6th April 2014
World Ophthalmology Congress (WOC) Booth E-21 – New data presented on Rho kinase inhibitor K-115 in the treatment of primary open-angle glaucoma and ocular hypertension
31st May – 3rd June 2014
82nd European Atherosclerosis Society (EAS) Congress – Spanish experts offer guidance on the use of statins in people at risk of developing diabetes mellitus
13th – 17th September 2014
Kowa are attending the European Society of Cataract and Refractive Surgeons (ESCRS) Congress – come and visit us at our booth B03
25th – 28th September 2014
Kowa are attending Deutsche Ophthalmologische Gesellschaft (DOG) – come and visit us at our booth B.06
“Kowa is committed to the healthcare global community.”
Our entrepreneurial initiative means we’re determined to meet future needs.
Expand your horizons
Come and visit us at our booth at DOG ─ B.06
25th – 28th September